StuartC.GordonMD

PubMed

• The Health Care Burden of Hepatic Encephalopathy.
  Kevin B Harris, Humberto C Gonzalez, Stuart C Gordon> ;Clinics in Liver Disease. 2024 May 1
• Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis.
  Mei Lu, Loralee B Rupp, Christina Melkonian, Sheri Trudeau, Yihe G Daida, Mark A Schmidt, Stuart C Gordon> ;Advances in Therapy. 2024 Apr 10
• 1 citations
  Primary Biliary Cholangitis: Epidemiology, Diagnosis, and Presentation.
  Muhammad Salman Faisal, Humberto C Gonzalez, Stuart C Gordon> ;Clinics in Liver Disease. 2024 Feb 1
• Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis.
  Mei Lu, Loralee B Rupp, Christina Melkonian, Sheri Trudeau, Yihe G Daida, Mark A Schmidt, Stuart C Gordon> ;Advances in Therapy. 2024 Feb 1
• Antiviral Treatment and Response are Associated With Lower Risk of Dementia Among Hepatitis C Virus-Infected Patients.
  Meng-Hua Tao, Stuart C Gordon, Trueman Wu, Sheri Trudeau, Loralee B Rupp, Humberto C Gonzalez, Yihe G Daida, Mark A Schmidt, Mei Lu> ;The American Journal of Geriatric Psychiatry. 2024 May 1
• Persistent pruritus associated with worse quality of life in patients with chronic hepatitis.
  Lu, M., Rupp, L., Melkonian, C., Trudeau, S., Daida, Y., Schmidt, M., Gordon, S.> ;Liver International. 2024 Feb 1
• 2 citations
  Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
  Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harr...> ;Alimentary Pharmacology & Therapeutics. 2024 Jan 1
• 1 citations
  Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic.
  Humberto C Gonzalez, Faisal M Nimri, Mei Lu, Yueren Zhou, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon> ;Hepatology International. 2023 Dec 1
• 1 citations
  Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C.
  Mei Lu, Reena Salgia, Jia Li, Sheri Trudeau, Loralee B Rupp, Trueman Wu, Yihe G Daida, Mark A Schmidt, Stuart C Gordon> ;Journal of Viral Hepatitis. 2023 Sep 1
• 1 citations
  Hepatic Manifestations of Systemic Diseases.
  Humberto C Gonzalez, Stuart C Gordon> ;The Medical Clinics of North America. 2023 May 1
• 5 citations
  Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
  Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C ...> ;Hepatology. 2023 Aug 1
• 2 citations
  Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antivirals.
  Ranya Selim, Stuart C Gordon, Yueren Zhou, Talan Zhang, Mei Lu, Yihe G Daida, Joseph A Boscarino, Mark A Schmidt, Sheri Trudeau, Loralee B Rupp, Humberto C Gonzalez> ;Journal of Viral Hepatitis. 2023 Jun 1
• Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States.
  Robert J Wong, Loralee Rupp, Mei Lu, Zeyuan Yang, Yihe G Daida, Mark Schmidt, Joseph A Boscarino, Stuart C Gordon, Amit S Chitnis> ;Journal of Viral Hepatitis. 2023 Jun 1
• 2 citations
  Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
  Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El-K...> ;Journal of Viral Hepatitis. 2023 Apr 1
• 1 citations
  Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global...
  Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, Gamal Esmat, Marlen I Castellanos Fernández, Maria Buti, Georgios Papatheodoridis, Yusuf Yilmaz, Vasily Isakov, Aja...> ;Journal of Viral Hepatitis. 2022 Nov 1
• 26 citations
  A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
  Christopher L Bowlus, Michael R Galambos, Richard J Aspinall, Gideon M Hirschfield, David E J Jones, Yvonne Dörffel, Stuart C Gordon, Stephen A Harrison, Andreas E Kre...> ;Journal of Hepatology. 2022 Aug 1
• Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals.
  Sheri Trudeau, Vivek Mendiratta, Yara Dababneh, Jennifer Hollingsworth, Stuart C Gordon> ;Hepatology. 2023 Jan 1
• Response to: 'No impact of Covid-19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan'.
  Humberto C Gonzalez, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon> ;Liver International. 2022 Aug 1
• 7 citations
  Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol-related liver disease.
  Ranya Selim, Yueren Zhou, Loralee B Rupp, Sheri Trudeau, Sandra Naffouj, Omar Shamaa, Abdelwahab Ahmed, Syed-Mohammed Jafri, Stuart C Gordon, Antu Segal, Humberto C Go...> ;Clinical Transplantation. 2022 May 1
• 22 citations
  Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA.
  Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon> ;Liver International. 2022 Apr 1
• 11 citations
  Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data.
  Young-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao, Jinlin Hou, Stuart C Gordon, John F Flaherty, Leland J Yee, Yang Zhao, Kosh Agarwal, Pietro ...> ;Alimentary Pharmacology & Therapeutics. 2022 Apr 1
• 9 citations
  Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
  W Ray Kim, Laura E Telep, Belinda Jump, Mei Lu, Heribert Ramroth, John Flaherty, Anuj Gaggar, Anand P Chokkalingam, Stuart C Gordon> ;Alimentary Pharmacology & Therapeutics. 2022 Apr 1
• Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States.
  Yueren Zhou, Jia Li, Stuart C Gordon, Sheri Trudeau, Loralee B Rupp, Joseph A Boscarino, Yihe G Daida, Mark A Schmidt, Mei Lu> ;Journal of Viral Hepatitis. 2022 Mar 1
• Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-A...
  Stuart C Gordon, Eyasu H Teshale, Philip R Spradling, Anne C Moorman, Joseph A Boscarino, Mark A Schmidt, Yihe G Daida, Loralee B Rupp, Sheri Trudeau, Jiaqi Zhang, Mei Lu> ;Clinical Infectious Diseases. 2022 Oct 12
• 20 citations
  Clinical and Patient Reported Outcomes from Patients with Non-alcoholic Fatty Liver Disease Across the World: Data from the Global NASH/NAFLD Registry.
  Zobair M. Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Ivón Castellanos Fernández, Vasily Isakov, Ajay Duseja, Nahum Méndez-Sánchez, Yuichiro Egu...> ;Clinical Gastroenterology and Hepatology. 2021 Nov 9
• Join now to see all